Vaccine Dosing Considerations in Product Labels and ACIP Recommendations: A Review
In the United States, the Food and Drug Administration (FDA) is the regulatory authority with the responsibility to evaluate scientific data included in each vaccine’s prescribing information (e.g., safety, indication(s) for use, and dosing schedule) based on several factors, including safety, quali...
Saved in:
| Main Authors: | Kunal Saxena, Kate Mevis, Sofia Toso, Elif Alyanak, Natasha Hansen, Aliana Potter, Molly Flannery, Mona Saraiya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/7/682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Considerations for the design and conduct of externally controlled trials for drug and biological products
by: A. S. Motrinchuk, et al.
Published: (2023-12-01) -
Analysis of RWD/RWE recommendations and guidelines for 2021. International experience on the example of USA
by: A. Kurylev
Published: (2022-11-01) -
Patient-reported outcome claims in European and United States orphan drug approvals
by: Szymon Jarosławski, et al.
Published: (2018-01-01) -
Activity of soil fluorescein diacetate (FDA) hydrolase under long-term fertilization
by: MA Xing-zhu
Published: (2010-07-01) -
Performance improvement of extreme multi-label classification using K-way tree construction with parallel clustering algorithm
by: Purvi Prajapati, et al.
Published: (2022-09-01)